111 related articles for article (PubMed ID: 31677212)
21. The role of knowledge, risk perceptions, and cues to action among Iranian women concerning cervical cancer and screening: a qualitative exploration.
Taghizadeh Asl R; Van Osch L; De Vries N; Zendehdel K; Shams M; Zarei F; De Vries H
BMC Public Health; 2020 Nov; 20(1):1688. PubMed ID: 33176743
[TBL] [Abstract][Full Text] [Related]
22. Experiences of women awaiting cervical CANCER screening results from selected hospitals in Accra, Ghana.
Osei EA; Appiah S; Oti-Boadi E; Hammond D; Awuah DB; Menlah A; Garti I; Baidoo M
BMC Public Health; 2022 Aug; 22(1):1467. PubMed ID: 35915420
[TBL] [Abstract][Full Text] [Related]
23. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
Brandt T; Wubneh SB; Handebo S; Debalkie G; Ayanaw Y; Alemu K; Jede F; von Knebel Doeberitz M; Bussmann H
BMC Public Health; 2019 Jul; 19(1):1026. PubMed ID: 31366402
[TBL] [Abstract][Full Text] [Related]
24. Could changing invitation and booking processes help women translate their cervical screening intentions into action? A population-based survey of women's preferences in Great Britain.
Ryan M; Waller J; Marlow LA
BMJ Open; 2019 Jul; 9(7):e028134. PubMed ID: 31300499
[TBL] [Abstract][Full Text] [Related]
25. Barriers to Cervical Cancer Screening and Treatment in the Dominican Republic: Perspectives of Focus Group Participants in the Santo Domingo Area.
Liebermann EJ; VanDevanter N; Shirazian T; Frías Gúzman N; Niles M; Healton C; Ompad D
J Transcult Nurs; 2020 Mar; 31(2):121-127. PubMed ID: 31046602
[No Abstract] [Full Text] [Related]
26. Recall Efforts Successfully Increase Follow-Up for Cervical Cancer Screening Among Women With Human Papillomavirus in Honduras.
Thomson KA; Sandoval M; Bain C; Holme F; Bansil P; Figueroa J; de Sanjosé S
Glob Health Sci Pract; 2020 Jun; 8(2):290-299. PubMed ID: 32606095
[TBL] [Abstract][Full Text] [Related]
27. Understanding HPV-positive women's needs and experiences in relation to patient-provider communication issues: a qualitative study.
Qaderi K; Geranmayeh M; Farnam F; Sheikh Hasani S; Mirmolaei ST
BMC Health Serv Res; 2021 Mar; 21(1):286. PubMed ID: 33784992
[TBL] [Abstract][Full Text] [Related]
28. Development and field testing of a tool to elicit women's preferences among cervical cancer screening modalities.
Wood B; Taljaard M; El-Khatib Z; McFaul S; Graham ID; Little J
J Eval Clin Pract; 2019 Dec; 25(6):1169-1181. PubMed ID: 31423705
[TBL] [Abstract][Full Text] [Related]
29. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
Ndejjo R; Mukama T; Kiguli J; Musoke D
BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
[TBL] [Abstract][Full Text] [Related]
30. Ethical issues evolving from patients' perspectives on compulsory screening for syphilis and voluntary screening for cervical cancer in Kenya.
Omondi Aduda DS; Mkhize N
BMC Med Ethics; 2014 Mar; 15():27. PubMed ID: 24678613
[TBL] [Abstract][Full Text] [Related]
31. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
32. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
33. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
34. Perspectives on cervical cancer screening among educated Muslim women in Dubai (the UAE): a qualitative study.
Khan S; Woolhead G
BMC Womens Health; 2015 Oct; 15():90. PubMed ID: 26496942
[TBL] [Abstract][Full Text] [Related]
35. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
[TBL] [Abstract][Full Text] [Related]
36. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
37. Exploring Effective Contextual Factors for Regular Cervical Cancer Screening in Iranian Women: A Qualitative Study.
Refaei M; Dehghan Nayeri N; Khakbazan Z; Yazdkhasti M; Shayan A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):533-539. PubMed ID: 29480997
[TBL] [Abstract][Full Text] [Related]
38. [Prophylaxis and screening of precancer and cancer of the uterine cervix in the XXI century].
Kostova P; Zlatkov V
Akush Ginekol (Sofiia); 2009; 48(1):41-5. PubMed ID: 19496464
[TBL] [Abstract][Full Text] [Related]
39. Screening for cancer of uterine cervix and approaches adopted in India.
Murthy NS; Mathew A
Indian J Cancer; 1999; 36(2-4):154-62. PubMed ID: 10921220
[TBL] [Abstract][Full Text] [Related]
40. Avoiding inappropriate invitations to cancer screening programmes: the role of primary care.
Campbell C; Anandan C; Appleton S; Elton R; Patnick J; Weller D
J Med Screen; 2011; 18(1):12-7. PubMed ID: 21536811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
